GB2359083B - Mutant herpes simplex viruses and uses thereof - Google Patents

Mutant herpes simplex viruses and uses thereof

Info

Publication number: GB2359083B
Authority: GB; United Kingdom
Prior art keywords: herpes simplex; simplex viruses; mutant herpes; mutant; viruses
Prior art date: 1998-05-20
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

GB0030820A

Other versions

GB2359083A (en

GB0030820D0 (en

Inventor

Robert Stuart Coffin

David Seymour Latchman

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Biovex Ltd

Original Assignee

Biovex Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-05-20

Filing date

1999-05-20

Publication date

2003-03-12

1999-05-20 Application filed by Biovex Ltd filed Critical Biovex Ltd

2001-01-31 Publication of GB0030820D0 publication Critical patent/GB0030820D0/en

2001-08-15 Publication of GB2359083A publication Critical patent/GB2359083A/en

2003-03-12 Application granted granted Critical

2003-03-12 Publication of GB2359083B publication Critical patent/GB2359083B/en

2019-05-20 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
- C12N2710/16641—Use of virus, viral particle or viral elements as a vector
- C12N2710/16643—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Genetics & Genomics (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Biomedical Technology (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
General Health & Medical Sciences (AREA)
General Engineering & Computer Science (AREA)
Biotechnology (AREA)
Biochemistry (AREA)
Medicinal Chemistry (AREA)
Microbiology (AREA)
Virology (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Physics & Mathematics (AREA)
Biophysics (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Molecular Biology (AREA)
Plant Pathology (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Immunology (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Investigating Or Analysing Biological Materials (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

GB0030820A 1998-05-20 1999-05-20 Mutant herpes simplex viruses and uses thereof Expired - Fee Related GB2359083B (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9810904.4A GB9810904D0 (en)	1998-05-20	1998-05-20	Mutant herpes simplex viruses and uses thereof
PCT/GB1999/001598 WO1999060145A1 (en)	1998-05-20	1999-05-20	Mutant herpes simplex viruses and uses thereof

Publications (3)

Publication Number	Publication Date
GB0030820D0 GB0030820D0 (en)	2001-01-31
GB2359083A GB2359083A (en)	2001-08-15
GB2359083B true GB2359083B (en)	2003-03-12

Family

ID=10832440

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
GBGB9810904.4A Ceased GB9810904D0 (en)	1998-05-20	1998-05-20	Mutant herpes simplex viruses and uses thereof
GB0030820A Expired - Fee Related GB2359083B (en)	1998-05-20	1999-05-20	Mutant herpes simplex viruses and uses thereof

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
GBGB9810904.4A Ceased GB9810904D0 (en)	1998-05-20	1998-05-20	Mutant herpes simplex viruses and uses thereof

Country Status (11)

Country	Link
EP (1)	EP1080215A1 (en)
JP (1)	JP2002515256A (en)
KR (1)	KR20010071292A (en)
CN (1)	CN1192112C (en)
AU (1)	AU756892B2 (en)
BR (1)	BR9910594A (en)
CA (1)	CA2328594A1 (en)
GB (2)	GB9810904D0 (en)
IL (1)	IL139745A0 (en)
MX (1)	MXPA00011346A (en)
WO (1)	WO1999060145A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6713067B2 (en)	1998-07-31	2004-03-30	Biovex Limited	Herpes viruses for immune modulation
GB0009079D0 (en) *	2000-04-12	2000-05-31	Neurovex Ltd	Herpes viruses for immune modulation
GB9930418D0 (en) *	1999-12-22	2000-02-16	Neurovex Ltd	Replication incompetent herpes virus vectors
BRPI0107736B8 (en)	2000-01-21	2021-05-25	Biovex Ltd	hsv1 js1 strain, pharmaceutical composition, and use of an hsv1 js1 strain
US7063851B2 (en)	2000-04-12	2006-06-20	Biovex Limited	Herpes viruses for immune modulation
EP1618214A4 (en) *	2003-04-25	2008-02-13	Becton Dickinson Co	Detection of herpes simplex virus types 1 and 2 by nucleic acid amplification
GB0317511D0 (en)	2003-07-25	2003-08-27	Biovex Ltd	Viral vectors
KR102382295B1 (en) *	2013-07-17	2022-04-04	유니버시티 오브 피츠버그-오브 더 커먼웰쓰 시스템 오브 하이어 에듀케이션	Non-toxic HSV vectors for efficient gene delivery applications and complementing cells for their production
GB201505860D0 (en)	2015-04-07	2015-05-20	Agalimmune Ltd	Therapeutic compositions and methods of use for treating cancer

Citations (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1996027672A1 (en) *	1995-03-08	1996-09-12	Glorioso Joseph C	Latency active herpes virus promoters and their use to treat neurological lesions
WO1997013866A2 (en) *	1995-10-11	1997-04-17	University Of British Columbia	Recombinant herpes virus vectors for expression in neuronal cells
WO1997020935A2 (en) *	1995-12-06	1997-06-12	Cambridge University Technical Services Limited	Viral vectors

1998
- 1998-05-20 GB GBGB9810904.4A patent/GB9810904D0/en not_active Ceased
1999
- 1999-05-20 AU AU39466/99A patent/AU756892B2/en not_active Ceased
- 1999-05-20 BR BR9910594-2A patent/BR9910594A/en not_active IP Right Cessation
- 1999-05-20 EP EP99922369A patent/EP1080215A1/en not_active Withdrawn
- 1999-05-20 KR KR1020007012952A patent/KR20010071292A/en not_active Ceased
- 1999-05-20 CA CA002328594A patent/CA2328594A1/en not_active Abandoned
- 1999-05-20 GB GB0030820A patent/GB2359083B/en not_active Expired - Fee Related
- 1999-05-20 WO PCT/GB1999/001598 patent/WO1999060145A1/en not_active Ceased
- 1999-05-20 CN CNB998089281A patent/CN1192112C/en not_active Expired - Fee Related
- 1999-05-20 JP JP2000549751A patent/JP2002515256A/en active Pending
- 1999-05-20 MX MXPA00011346A patent/MXPA00011346A/en unknown
- 1999-05-20 IL IL13974599A patent/IL139745A0/en unknown

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1996027672A1 (en) *	1995-03-08	1996-09-12	Glorioso Joseph C	Latency active herpes virus promoters and their use to treat neurological lesions
WO1997013866A2 (en) *	1995-10-11	1997-04-17	University Of British Columbia	Recombinant herpes virus vectors for expression in neuronal cells
WO1997020935A2 (en) *	1995-12-06	1997-06-12	Cambridge University Technical Services Limited	Viral vectors

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Molecular Medicine Today Sept.(09) 1997. Lachmann R H et.al.pages 404-411 *
Nucl. Acid Res. Vol. 18 (12) 1990. Morgenstern J P & Land H pages 3587-3596 *

Also Published As

Publication number	Publication date
WO1999060145A1 (en)	1999-11-25
GB2359083A (en)	2001-08-15
JP2002515256A (en)	2002-05-28
AU756892B2 (en)	2003-01-23
AU3946699A (en)	1999-12-06
CN1192112C (en)	2005-03-09
HK1036085A1 (en)	2001-12-21
IL139745A0 (en)	2002-02-10
EP1080215A1 (en)	2001-03-07
CA2328594A1 (en)	1999-11-25
KR20010071292A (en)	2001-07-28
GB0030820D0 (en)	2001-01-31
GB9810904D0 (en)	1998-07-22
CN1310765A (en)	2001-08-29
MXPA00011346A (en)	2003-05-19
BR9910594A (en)	2001-10-30

Publication	Publication Date	Title
GB2353529B (en)	2003-01-15	Mutant herpes simplex viruses and uses thereof
IL141044A0 (en)	2002-02-10	Innunological herpes simplex virus antigens and methods for use thereof
AU4208799A (en)	1999-12-13	Interleukins-21 and 22
IL128869A0 (en)	2000-01-31	Pyrozolopyrimidines and pyrazolotriazines
EP1032377A4 (en)	2006-06-14	Substituted 2-aminoacetamides and the use thereof
AU3548099A (en)	1999-10-18	Progression elevated gene-3 and uses thereof
GB9415369D0 (en)	1994-09-21	Mutant virus
EP1102091A4 (en)	2004-04-28	Reflecting sheet and reflecting/semitransmitting sheet
HU9903361D0 (en)	1999-12-28	Filter-device with collecting-vessel and with heating-device
AU9781998A (en)	1999-04-12	Huchordin and uses thereof
GB2359083B (en)	2003-03-12	Mutant herpes simplex viruses and uses thereof
GB9816761D0 (en)	1998-09-30	Herpesvirus preparations and their uses
AU6884298A (en)	1998-10-30	Viral obesity methods and compositions
AU6962698A (en)	1998-11-11	Transgenomic viruses and the use thereof
AU4582899A (en)	2000-01-10	Mutated herpes simplex virus type 1 thymidine kinases and uses thereof
AU8227498A (en)	1999-01-25	Improvements in burners
HK1036085B (en)	2003-08-29	Mutant herpes simplex viruses and uses thereof
HK1035378B (en)	2003-05-30	Mutant herpes simplex viruses and uses thereof
AU4018395A (en)	1996-06-17	Compounding elements and use thereof
GB9825136D0 (en)	1999-01-13	Flat torch and manufacture thereof
GB9714877D0 (en)	1997-09-17	Microorganism and its use
IL139961A0 (en)	2002-02-10	Composition based on pentoxifylline and anticytokin
HUP0104954A3 (en)	2004-07-28	Prv-1 gene and the use thereof
ZA987425B (en)	1999-02-22	Phenylethanolaminotetralin derivatives and bronchodilators
GB9803809D0 (en)	1998-04-22	The strimmer and rotovar adaptor

Legal Events

Date	Code	Title	Description
2007-01-24	PCNP	Patent ceased through non-payment of renewal fee	Effective date: 20060520